Overview
The HTA Policy and Methods Review was informed by papers analysing:
- contemporary research, relevant methodologies and purchasing practices used by comparable international jurisdictions
- their applicability to the Australian context.
To find out more about the evidence supporting the review, see the research and analysis plan overview.
Papers by HTA experts
The HTA Review Reference Committee agreed to commission 3 expert groups in HTA to prepare research and analysis papers to support the HTA Review.
Adelaide Health Technology Assessment (AHTA)
- Paper 1. International health technology market approval, funding and assessment pathways
- Paper 2. Horizon scanning and early value assessment
- Paper 3. HTA methods: Determination of population, intervention, comparator, outcome (PICO)
- Paper 4. HTA methods: Clinical evaluation
- Attachment 1: Detailed country profiles – HTA pathways and processes, clinical evaluation methods and horizon scanning
The final versions of the above papers have been combined into a single paper – HTA pathways and processes, clinical evaluation methods and horizon scanning.
Centre for Health Economics Research and Evaluation (CHERE)
Centre of Research Excellence in Medicines Intelligence (MI-CRE)
Department of Health and Aged Care
Documents referenced by the review
The following documents were not commissioned by the reference committee but were used to support and inform the HTA Review:
- Strategic Agreement 2022-2027
- National Medicines Policy
- National Agreement on Closing the Gap
- Australian Government response to the inquiry into approval processes for new drugs and novel medical technologies
- Review of the discount rate in the PBAC guidelines
- PBAC public summary document: Review of the base discount rate in the PBAC guidelines
Date last updated: